| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:450549639:1899 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:450549639:1899?format=raw |
LEADER: 01899cam a2200433 a 4500
001 3907056
005 20221026235619.0
008 820929t19811981nyua b 101 0 eng
010 $a 80005900
020 $a0890046972
035 $a(OCoLC)7835227
035 $a(OCoLC)ocm07835227
035 $a(CStRLIN)NYCG82-B45324
035 $9AAL9305HS
035 $a(NNC)3907056
035 $a3907056
040 $dNNC-M
050 00 $aRC271.I45$bL95
060 0 $aW1 PR667M v. 20$aQZ 267 L986 1981
082 0 $a616.99/4061$219
245 00 $aLymphokines and thymic hormones :$btheir potential utilization in cancer therapeutics /$ceditors, Allan L. Goldstein, Michael A. Chirigos.
260 $aNew York :$bRaven Press,$c[1981], ©1981.
300 $axviii, 324 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aProgress in cancer research and therapy ;$vv. 20
504 $aIncludes bibliographical references and index.
650 0 $aImmunotherapy.$0http://id.loc.gov/authorities/subjects/sh85064592
650 0 $aCancer$xImmunological aspects.$0http://id.loc.gov/authorities/subjects/sh85019512
650 0 $aLymphokines$xTesting.
650 0 $aThymic hormones$xTesting.
650 2 $aLymphokines$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D008222Q000627
650 2 $aThymus Hormones$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D013951Q000627
650 2 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aGoldstein, Allan L.$0http://id.loc.gov/authorities/names/n78022746
700 1 $aChirigos, Michael A.$0http://id.loc.gov/authorities/names/n80153977
830 0 $aProgress in cancer research and therapy ;$vv. 20.$0http://id.loc.gov/authorities/names/n42019860
852 00 $boff,hsl$hRC271.I45$iL98 1981